Evidence-based Medicine & Health Technology Assessment: Moving From Separate Appraisals to Synergistic Communications

SESSION TOPICS

·         Overview of Evidence-Based Medicine (EBM) and Health Technology Assessment (HTA)

·         Evidence Hierarchies and Methodological Best Practices

·         Use of Evidence and HTA in Coverage Decisions

·         Use of Evidence and EBM in Clinical Guidelines Development

·         Expert Panel Discussion on EBM and HTA for Decision-making

At the conclusion of this meeting, participants should be able to:

·         Compare and contrast the methods and data sources for evidence generation and evaluation that support EBM and HTA;

·         Differentiate the processes employed for HTA across public and private payers in the US and other countries;

·         Participate in the generation or evaluation of HTAs and the promotion of EBM that is scientifically rigorous and achievable; and

·         Discuss the legal implications and market demands surrounding dissemination of evidence-based information that both decision-makers and other healthcare individuals need to see.

This program will benefit individuals involved in:

·         Evidence-based medicine and quality health care

·         Research that generates and analyzes evidence for drug approvals and formulary decision-making

·         Making coverage decisions and managing pharmacy spending

·         Pharmaceutical manufacturing that produces evidence for NDAs and formulary dossiers

·         Reviewing evolving data on safety, effectiveness and affordability of health care

Contact Wendy Moyer at the DIA office in Horsham, PA by telephone +1.215.293.5810,
fax +1.215.442.6199, or email Wendy.Moyer@diahome.org